News
Latest
News
Paulo Fontoura to lead research and development at Sanofi
Taking over from Dr Houman Ashrafian, the 25-year industry veteran will help to advance the firm’s innovation strategy.
Join now
Unlock exclusive industry insights
- Bookmark articles and resources to access anytime
- Enjoy free access to industry leading resources, webinars and insights
- Stay informed with the latest news and breakthroughs in drug discovery
- Receive updates and recommendations tailored to your research interests
Special reports
NewsJohnson & Johnson’s Caplyta demonstrates phase III promise for depression
Combination therapy comprising of an antidepressant and small molecule drug significantly boosted remission rates in adults with major depressive disorder.
NewsChemical assessment in Europe to be streamlined under new legislation
The European Commission’s new framework aims to improve safety assessment of chemicals to better protect human health and the environment.
NewsEndotoxin testing milestone reached with European Pharmacopoeia’s animal shift
The quality control (QC) standards publication sets animal-free bacterial endotoxins testing (BET) as the new norm in Europe.
NewsImpurities findings could enhance peptide drug safety
EpiVax and Cubrc research supports FDA guidance on impurity risk assessment in generic peptides.
Opinion
- Previous
- Next
All news articles
News
Recipharm makes major investment to expand US sterile manufacturing footprint
Decision strengthens the CMDO’s fill-finish operations and increases capacity for biologics and advanced therapies.
News
MHRA green lights lower dose EURneffy nasal spray for children
Needle-free allergy adrenaline treatment expands options beyond injection for younger UK patients for first time.
News
Petri dish study could enhance accuracy of microbiological testing
Findings may help mitigate moisture-related issues when using Reasoner’s agar (R2A) during microbial water quality testing.
News
MHRA targets medicine safety with new AI sandbox
Agency’s new AI initiative will provide an evidence-based programme to encourage pharmaceutical companies to invest in innovation in the UK.
News
GSK advances oncology efforts with $10.6bn Nuvalent acquisition
Multi-product oncology deal accelerates GSK’s entry into lung cancer.
News
Gilead-MSD once-weekly oral HIV regimen meets Phase III endpoints
Combining islatravir/lenacapavir could provide alternative to daily antiretroviral therapy for virologically suppressed patients with HIV.
News
Roche and Nurix to advance potential best-in-class BTK degrader bexobrutideg
Collaboration agreement expands Roche’s oncology pipeline and offers therapeutic potential across immunology and neurology.
News
Amgen’s Imdylltra approved in Europe for aggressive solid tumour
Milestone authorisation represents the first T-cell engagement therapy for small cell lung cancer.
News
CorrectSequence’s base-editing therapy shows preliminary success in sickle cell disease
Achievement of study’s primary efficacy endpoint positions therapy as potentially safer and more effective approach to CRISPR-based gene-editing therapies.
News
EU Commission issues plan to replace animal testing in chemical safety assessments
Publication marks a significant step towards modernising chemical safety assessments in Europe.
News
Biologics growth expected to reshape pharmaceutical packaging demand
Evolving regulatory requirements and ensuring product sterility and stability are driving demand for packaging innovation, particularly for biologic medicines, research suggests.
News
Lilly licenses Hanmi’s GLP-2 biologic sonefpeglutide for $1.2bn
Agreement to develop and commercialise long-acting GLP drug candidate by South Korea-based biopharma company.
News
Idorsia’s glycan-targeting C diff. vaccine maintains positive clinical trajectory
Higher-dose cohort builds on earlier study data, positioning the synthetic glycan vaccine for future development.
News
Pfizer partners with Innovent for $10.5bn to advance ADC oncology medicines
Licensing agreement builds on Innovent Biologics’ earlier $11 billion collaboration with Takeda to develop novel ADC and immuno-oncology candidates.
News
Novel CAR T manufacturing process significantly cuts production time
Efficacy findings comparable to those of existing CAR T cell therapies for relapsed/refractory multiple myeloma (r/r MM).
News
Day two in focus: navigating regulatory strategy at The Future of Bio/Pharmaceutical Analysis 2026
Day two of The Future of Bio/Pharmaceutical Analysis Virtual Summit 2026 focuses exclusively on regulatory strategy, with three panel sessions examining how compliance and quality pressures are reshaping how biopharma companies operate. From nitrosamine management to GLP-1 product quality, and from US agency dynamics to European regulatory reform, the programme addresses the practical challenges facing QA/QC professionals responsible for maintaining product safety and compliance in an increasingly complex drug development and manufacturing landscape.
News
Eli Lilly bolsters infectious disease portfolio with acquisitions totalling $3.8bn
Investments in Curevo, LimmaTech Biologics and Vaccine Company set to advance vaccines for shingles, AMR-driving pathogens and Epstein-Barr Virus.
News
Pharming secures novel EU approval for Joenja in activated PI3K delta syndrome
European approval provides a targeted approach that addresses the underlying pathophysiology of activated PI3K delta syndrome (APDS).
News
Macrophage cell therapy signals advancement in regenerative medicine
Treatment has potential to reduce the need for liver transplants in those with cirrhosis, long-term data suggests.
News
Optimised semaglutide formulation could advance peptide-based oral delivery
Study provides insight on enhancing the formulation development of GLP-1-targeting therapies for obesity and diabetes.